Generex Biotechnology Corporation

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions...

Oral insulin,cancer vaccines,research and development,large molecule,buccal deliver,vaccine development,diabetes solutions,physician network,diabetes clinic,immuno-oncology,covid19 vaccine,infectious diseases,wound healing,wound management,ulcer colitis management,ibd solutions,diagnostic kits,sepsis diagnostic kit,hiv diagnostic kit,hospital diagnostic kits,durable medical equipment,physician mso,pharmacy network,ophthamologists,and orthopedic surgeons

Generex biotechnology corporation operates in the Biotechnology research industry.

Generex biotechnology corporation's revenue is 11m - 100m

Generex biotechnology corporation has 11 - 50 employees.